Oncology

A recent study introduces an advanced ex vivo 3D micro-tumour testing platform that accurately forecasts individual patient response to chemotherapy, potentially revolutionizing personalized treatment decisions.

Minimal residual disease (MRD) is a major barrier to curing advanced ovarian cancer, even in patients who appear disease-free after initial therapy. A recent study of 95 patients showed that MRD detected through second-look laparoscopy or circulating tumor DNA strongly predicted shorter progression-free and overall survival.

A proteome-wide genetic study found that the protein FSHB is strongly associated with increased risk of endometrioid ovarian cancer.

Childhood cancer survivors who are obese and less physically active face a significantly higher risk of developing subsequent cancers later in life, according to new research….

A groundbreaking AI model, trained on over 1.3 million MRI–pathology pairs, is redefining prostate cancer diagnosis. The MRI‑PTPCa system delivers near‑perfect accuracy in grading tumors, offering a safe, noninvasive alternative to biopsies while improving clinical decision‑making and patient outcomes.

Survivors of childhood cancer who live past age 50 face a significantly higher risk of premature death and serious health problems compared with the general population…

A new study has revealed how subtle oxidative modifications of proteins fine-tune cell division and determine how cells respond to stress. Read on to learn more!

Lower vitamin D levels linked to higher thyroid cancer risk, new meta-analysis suggests clinical importance.